TwinStar Tablet 80/5 mg

Adult dose

The recommended dosage for this medication is 1 tablet once daily, to be taken with water regardless of meals. It is advisable to take it at the same time each day (e.g., in the morning). The medication is administered when blood pressure control with dosages of 40/5 mg, 80/5 mg, or 40/10 mg is insufficient; for patients with renal impairment, lower starting doses should be considered in severe cases, and dose increments should be done gradually. For patients with liver dysfunction, the daily dosage of telmisartan should not exceed 40 mg.

Child dose

Safety and efficacy in pediatric patients under 18 years of age have not been established; therefore, administration of this medication is not recommended.

This medication should not be taken during pregnancy, especially during the second and third trimesters, as it can cause serious side effects to the fetus. If pregnancy is confirmed, this medication should be discontinued as soon as possible and replaced with a safer alternative if necessary. This medication is contraindicated in patients with certain diseases, such as severe liver dysfunction, biliary obstruction, severe hypotension, and those experiencing shock related to heart conditions. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. Caution is advised when administering this medication to certain patients, such as those with primary aldosteronism, certain heart valve diseases, liver dysfunction, gastrointestinal diseases, renovascular hypertension, renal failure, and the elderly; these patients should use this medication carefully under medical supervision. Common side effects during the use of this medication may include dizziness and peripheral edema, while serious side effects such as fainting can occur rarely. If any unusual symptoms appear, immediate consultation with a healthcare professional is required. This medication can interact with other drugs, so it is essential to inform healthcare professionals if taking other medications. In particular, when taken with medications that can affect potassium levels, regular monitoring of serum potassium concentrations is necessary. This medication contains sorbitol and is not suitable for patients with fructose intolerance. Caution is also needed while driving or operating machinery due to possible dizziness or drowsiness. In case of overdose, hypotension, cardiac arrhythmias, and in severe cases, shock may occur, requiring immediate medical treatment. This medication has not been established for safety and efficacy in children, hence it is not recommended for them.

Serious side effects

Urticaria, severe swelling (edema), cold sweat, pallor, severe allergic reactions, severe rash with high fever, blisters, skin peeling, pain in the oral/ocular mucosa, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory issues accompanied by cough and fever, jaundice, extreme fatigue, liver abnormalities (jaundice), sudden and severe headache, thunderclap headache.

Mild side effects

• Dizziness
• peripheral edema
• upper respiratory infection
• urinary tract infection
• cystitis
• anemia
• hyperkalemia
• hypoglycemia
• hyponatremia
• hyperglycemia

This medication is sensitive to light and should be stored in an opaque container. Additionally, it is essential to maintain a room temperature between 1°C and 30°C while storing the medication. Avoid storing in excessively hot or cold places.

Appearance

A white and light blue, oval-shaped biconvex double tablet.

Package unit

30 tablets (10 tablets/PTP x 3)